Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Caroline Ruetsch-Chelli"'
Autor:
Mikaël Chelli, Jules Descamps, Vincent Lavoué, Christophe Trojani, Michel Azar, Marcel Deckert, Jean-Luc Raynier, Gilles Clowez, Pascal Boileau, Caroline Ruetsch-Chelli
Publikováno v:
Journal of Medical Internet Research, Vol 26, p e53164 (2024)
BackgroundLarge language models (LLMs) have raised both interest and concern in the academic community. They offer the potential for automating literature search and synthesis for systematic reviews but raise concerns regarding their reliability, as
Externí odkaz:
https://doaj.org/article/ec1a9d0c24384d3d914d5c02f6fc50fa
Autor:
Marion Cremoni, Jonathan Allouche, Daisy Graça, Kevin Zorzi, Céline Fernandez, Maxime Teisseyre, Sylvia Benzaken, Caroline Ruetsch-Chelli, Vincent L. M. Esnault, Jean Dellamonica, Michel Carles, Jérôme Barrière, Michel Ticchioni, Vesna Brglez, Barbara Seitz-Polski
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The SARS-CoV-2 infection has spread rapidly around the world causing millions of deaths. Several treatments can reduce mortality and hospitalization. However, their efficacy depends on the choice of the molecule and the precise timing of its administ
Externí odkaz:
https://doaj.org/article/4f79c042d683422bbe72d2174e167790
Autor:
Thierry Passeron, Alexandre Gérard, Jerome Doyen, Marion Cremoni, Laurent Bailly, Kevin Zorzi, Caroline Ruetsch-Chelli, Vesna Brglez, Alexandra Picard-Gauci, Laura Troin, Vincent L.M. Esnault, Henri Montaudié, Barbara Seitz-Polski
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background Despite significant progress with antiprogrammed cell death protein 1 (PD-1) therapy, a substantial fraction of metastatic melanoma patients show upfront therapy resistance. Biomarkers for outcome are missing and the association of baselin
Externí odkaz:
https://doaj.org/article/36baee766c114b4fbed2bdf963c3dadd
Autor:
Daisy Graça, Vesna BRGLEZ, Jonathan ALLOUCHE, Caroline Ruetsch-Chelli, Kévin ZORZI, Céline FERNANDEZ, Maxime Teisseyre, Marion CREMONI, Christian Pradier, Sylvia BENZAKEN, Barbara Seitz-Polski
COVID-19 vaccines have significantly decreased the number severe cases of the disease but the virus circulation remains important and questions about the need of new vaccination campaigns remain unanswered. The individual’s protection against SARS-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b31f8b76a490ae6bbe4d41feb0d50f1b
https://doi.org/10.21203/rs.3.rs-2483361/v1
https://doi.org/10.21203/rs.3.rs-2483361/v1
Autor:
Caroline Ruetsch-Chelli, Darin T. Okuda, Fanny Rocher, Sophie Tartare-Deckert, Marcel Deckert, Christine Lebrun-Frenay
Publikováno v:
Neurology and therapy.
S1PFour S1PAt therapeutic doses, median confluence increased overall for all lineages: + 122% for ozanimod (p 0.001), + 71% for ponesimod (p 0.001), + 67% for siponimod (NS), and + 41% for fingolimod (p = 0.094). Ozanimod- and ponesimod-treated cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7576cf70799e4f37a29be121c14d4547
https://pubmed.ncbi.nlm.nih.gov/36534273
https://pubmed.ncbi.nlm.nih.gov/36534273
Autor:
Chris Wincup, Nicky Dunn, Caroline Ruetsch-Chelli, Ali Manouchehrinia, Nastya Kharlamova, Meena Naja, Barbara Seitz-Polski, David A Isenberg, Anna Fogdell-Hahn, Coziana Ciurtin, Elizabeth C Jury
Publikováno v:
Rheumatology (Oxford, England).
Objectives High rates of anti-drug antibodies (ADA) to rituximab have been demonstrated in patients undergoing treatment for SLE. However, little is known with regard to their long-term dynamics, impact on drug kinetics and subsequent implications fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5503c0f4ba5c6a8f493efd822e13a9
https://pubmed.ncbi.nlm.nih.gov/36370065
https://pubmed.ncbi.nlm.nih.gov/36370065
Autor:
Chris Wincup, Nicky Dunn, Caroline Ruetsch-Chelli, Ali Manouchehrinia, Nastya Kharlamova, Meena Naja, Barbara Seitz-Polski, David Isenberg, Anna Fogdell-Hahn, Coziana Ciurtin, Elizabeth Jury
Publikováno v:
Rheumatology. 61
Background/Aims A major limitation of biologic therapy is formation of anti-drug antibodies (ADA). We previously demonstrated that ADA to rituximab are more prevalent in patients undergoing treatment for systemic lupus erythematosus (SLE) than rheuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26dac2f786fff800b04570e02bb79ca9
https://doi.org/10.1093/rheumatology/keac133.242
https://doi.org/10.1093/rheumatology/keac133.242
Autor:
Marion Cremoni, Jonathan Allouche, Daisy Graça, Kevin Zorzi, Céline Fernandez, Maxime Teisseyre, Sylvia Benzaken, Caroline Ruetsch-Chelli, Vincent LM Esnault, Jean Dellamonica, michel Carles, Jérôme Barrière, Vesna Brglez, Barbara Seitz-Polski
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2e1bd49f6534586a7b56c6c1801b7ad
https://doi.org/10.2139/ssrn.4095756
https://doi.org/10.2139/ssrn.4095756
Autor:
Daisy Graça, Vesna Brglez, Jonathan Allouche, Caroline Ruetsch-Chelli, Kevin Zorzi, Céline Fernandez, Maxime Teisseyre, Marion Cremoni, Sylvia Benzaken, Barbara Seitz-Polski
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1839393df6f1ab162dfea67b4eb337b
https://doi.org/10.2139/ssrn.4309647
https://doi.org/10.2139/ssrn.4309647
Autor:
Vesna Brglez, Barbara Seitz-Polski, Michel Ticchioni, Mikael Cohen, Alessandra Rosenthal, Claude Desnuelle, Christine Lebrun-Frenay, Saskia Bresch, Caroline Ruetsch-Chelli
Publikováno v:
Neurotherapeutics
Myasthenia gravis can be efficiently treated with rituximab but there is no consensus regarding administration and dose schedules in this indication. No marker has yet been described to predict the clinical relapse of patients. Our objective was to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e85f1fd70da2e9be839d8b7ee49754
https://pubmed.ncbi.nlm.nih.gov/33768513
https://pubmed.ncbi.nlm.nih.gov/33768513